Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 397642, 13 pages
http://dx.doi.org/10.1155/2013/397642
Research Article

Carrageenan-Induced Colonic Inflammation Is Reduced in Bcl10 Null Mice and Increased in IL-10-Deficient Mice

1Department of Medicine, University of Illinois at Chicago, 840 S Wood Street, CSN 440 M/C 718, Chicago, IL 60612, USA
2Jesse Brown VA Medical Center, Chicago, IL 60612, USA
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA
4Department of Medicine, University of Chicago, Chicago, IL 02215, USA
5Joslin Diabetes Center, Boston, MA 60637, USA

Received 25 February 2013; Revised 29 April 2013; Accepted 8 May 2013

Academic Editor: Assaf Rudich

Copyright © 2013 Sumit Bhattacharyya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Macher and U. Galili, “The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance,” Biochimica et Biophysica Acta, vol. 1780, no. 2, pp. 75–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. W. R. Blakemore and A. R. Harpell, “Carrageenan,” in Food Stabilisers, Thickeners and Gelling Agents, Ullman’s Encyclopedia of Industrial Chemistry, chapter 5, pp. 73–94, John Wiley & Sons, New York, NY, USA, 2009. View at Publisher · View at Google Scholar
  3. S. Bhattacharyya, A. Borthakur, P. K. Dudeja, and J. K. Tobacman, “Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells,” The American Journal of Physiology, vol. 292, no. 3, pp. G829–G838, 2007. View at Google Scholar
  4. S. Bhattacharyya, R. Gill, L. C. Mei et al., “Toll-like receptor 4 mediates induction of the Bcl10-NFκB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells,” The Journal of Biological Chemistry, vol. 283, no. 16, pp. 10550–10558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. K. Tobacman, “Review of harmful gastrointestinal effects of carrageenan in animal experiments,” Environmental Health Perspectives, vol. 109, no. 10, pp. 983–994, 2001. View at Google Scholar · View at Scopus
  6. IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, “Carrageenan,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 31, pp. 79–94, 1983. View at Google Scholar
  7. S. Bhattacharyya, P. K. Dudeja, and J. K. Tobacman, “Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10,” Biochimica et Biophysica Acta, vol. 1780, no. 7-8, pp. 973–982, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bhattacharyya, A. Borthakur, S. Tyagi et al., “B-cell CLL/lymphoma 10 (BCL10) is required for NF-κB production by both canonical and noncanonical pathways and for NF-κB-inducing kinase (NIK) phosphorylation,” The Journal of Biological Chemistry, vol. 285, no. 1, pp. 522–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bhattacharyya, A. Borthakur, A. N. Anbazhagan, S. Katyal, P. K. Dudeja, and J. K. Tobacman, “Specific effects of BCL10 serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan,” The American Journal of Physiology, vol. 301, no. 3, pp. G475–G486, 2011. View at Google Scholar
  10. A. Borthakur, S. Bhattacharyya, A. N. Anbazhagan, A. Kumar, P. K. Dudeja, and J. K. Tobacman, “Prolongation of carrageenan-induced inflammation in human colonic epithelial cells by activation of an NFκB-BCL10 loop,” Biochimica et Biophysica Acta, vol. 1822, no. 8, pp. 1300–1307, 2012. View at Publisher · View at Google Scholar
  11. S. Bhattacharyya, H. Liu, Z. Zhang et al., “Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds,” Journal of Nutritional Biochemistry, vol. 21, no. 10, pp. 906–913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bhattacharyya, I. O-Sullivan, S. Katyal, T. Unterman, and J. K. Tobacman, “Exposure to common food additive carrageenan leads to glucose intolerance, insulin resistance, and inhibition of insulin signaling in HepG2 cells and C57BL/6J mice,” Diabetologia, vol. 55, no. 1, pp. 194–208, 2012. View at Publisher · View at Google Scholar
  13. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Song, K. H. Kim, J. M. Yoon, and J. B. Kim, “Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 739–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. K. Mohammad, M. Morran, B. Slotterbeck et al., “Dysregulated toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse,” International Immunology, vol. 18, no. 7, pp. 1101–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Amdekar, P. Roy, V. Singh, A. Kumar, R. Singh, and P. Sharma, “Anti-inflammatory activity of lactobacillus on carrageenan-induced paw edema in male wistar rats,” International Journal of Inflammation, vol. 2012, Article ID 752015, 6 pages, 2012. View at Publisher · View at Google Scholar
  17. F. Ma, C. Chen, L. Zheng, C. Zhou, K. Cai, and Z. Han, “Effect of high pressure processing on the gel properties of salt-soluble meat protein contain CaCl2 and κ-carrageenan,” Meat Science, vol. 95, no. 1, pp. 22–26, 2013. View at Publisher · View at Google Scholar
  18. E. Popa, R. Reis, and M. Gomes, “Chondroigenic phenotype of different cells encapsulated in κ-carrageenan hydrogels for cartilage regeneration strategies,” Biotechnology and Applied Biochemistry, vol. 59, no. 2, pp. 132–141, 2012. View at Publisher · View at Google Scholar
  19. R. Eccles, C. Meier, M. Jawad, R. Weinmüllner, A. Grassauer, and E. Prieschl-Grassauer, “Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold,” Respiratory Research, vol. 11, article 108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Simkhada, S. S. Cho, P. Mander, Y. H. Choi, and J. C. Yoo, “Purification, biochemical properties and antithrombotic effect of a novel Streptomyces enzyme on carrageenan-induced mice tail thrombosis model,” Thrombosis Research, vol. 129, no. 2, pp. 176–182, 2012. View at Publisher · View at Google Scholar
  21. L. Xue, S. W. Morris, C. Orihuela et al., “Defective developmental and function of Bcl10-deficient follicular, marginal zone and B1 B cells,” Nature Immunology, vol. 4, no. 9, pp. 857–865, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Zhang, R. Siebert, M. Yan et al., “Inactivating mutations and overexpression of BCL 10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32),” Nature Genetics, vol. 22, no. 1, pp. 63–68, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Li, H. Wang, L. Xue et al., “Eμ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-κB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma,” Blood, vol. 114, no. 19, pp. 4158–4168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Wang, Y. You, P. C. Lin et al., “Bcl10 plays a critical role in NF-κB activation induced by G protein-couple receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 145–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Klemm, S. Zimmermann, C. Peschel, T. W. Mak, and J. Ruland, “Bcl10 and Malt1 control lysophosphatidic acid-induced NF-κB activation and cytokine production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 134–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. McAllister-Lucas, J. Ruland, K. Siu et al., “CARMA3/Bcl10/MALT1-dependent NF-κB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 139–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Van Beek, K. I. Oravecz-Wilson, P. C. Delekta et al., “Bcl10 links saturated fat overnutrition with hepatocellular NF-κB activation and insulin resistance,” Cell Reports, vol. 1, no. 5, pp. 444–452, 2012. View at Publisher · View at Google Scholar
  28. S. Marion, J. Mazzolini, F. Herit et al., “The NF-κB signaling protein Bcl10 regulates actin dynamics by controlling AP1 and OCRL-bearing vesicles,” Developmental Cell, vol. 23, no. 5, pp. 954–967, 2012. View at Google Scholar
  29. S. Rosebeck, A. O. Rehman, P. C. Lucas, and L. M. McAllister-Lucas, “From MALT lymphoma to the CBM signalosome: three decades of discovery,” Cell Cycle, vol. 10, no. 15, pp. 2485–2496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. M. McAllister-Lucas, X. Jin, S. Gu et al., “The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis,” The Journal of Biological Chemistry, vol. 285, no. 34, pp. 25880–25884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Stilo, E. Varricchio, D. Liguoro, A. Leonardi, and P. Vito, “A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-κB,” Journal of Cell Science, vol. 121, no. 8, pp. 1165–1171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Devkota, Y. Wang, M. W. Musch et al., “Dietary fat induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/- mice,” Nature, vol. 487, no. 7405, pp. 104–108, 2012. View at Google Scholar
  33. M. P. Moyer, L. A. Manzano, R. L. Merriman, J. S. Stauffer, and L. R. Tanzer, “NCM460, a normal human colon mucosal epithelial cell line,” In vitro Cellular & Developmental Biology, Animal, vol. 32, no. 6, pp. 315–317, 1996. View at Google Scholar · View at Scopus
  34. S. Bhattacharyya, N. Pant, P. K. Dudeja, and J. K. Tobacman, “Development, evaluation, and application of a highly sensitive microtiter plate ELISA for human Bcl10 protein,” Journal of Immunoassay and Immunochemistry, vol. 28, no. 3, pp. 173–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Costa, M. G. Mumolo, M. Bellini et al., “Role of faecal calprotectin as non-invasive marker of intestinal inflammation,” Digestive and Liver Disease, vol. 35, no. 9, pp. 642–647, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. C. K. Ameho, A. A. Adjei, E. K. Harrison et al., “Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis,” Gut, vol. 41, no. 4, pp. 487–493, 1997. View at Google Scholar · View at Scopus
  37. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Müller, “Interleukin-10-deficient mice develop chronic enterocolitis,” Cell, vol. 75, no. 2, pp. 263–274, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. E. O. Glocker, D. Kotlarz, C. Klein, N. Shah, and B. Grimbacher, “IL-10 and IL-10 receptor defects in humans,” Annals of the New York Academy of Sciences, vol. 1246, pp. 102–107, 2011. View at Publisher · View at Google Scholar
  39. M. C. Li and S. H. He, “IL-10 and its related cytokines for treatment of inflammatory bowel disease,” World Journal of Gastroenterology, vol. 10, no. 5, pp. 620–625, 2004. View at Google Scholar · View at Scopus
  40. S. Cuzzocrea, E. Mazzon, L. Dugo et al., “Absence of endogenous interleukin-10 enhances the evolution of acute lung injury,” European Cytokine Network, vol. 13, no. 3, pp. 285–297, 2002. View at Google Scholar · View at Scopus
  41. F. D'Acquisto, A. Ianaro, A. Ialenti, T. Iuvone, V. Colantuoni, and R. Carnuccio, “Activation of nuclear transcription factor κB in rat carrageenin-induced pleurisy,” European Journal of Pharmacology, vol. 369, no. 2, pp. 233–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Ellis, V. Gilston, C. C. Y. Soo, C. J. Morris, B. L. Kidd, and P. G. Winyard, “Activation of the transcription factor NF-κB in the rat air pouch model of inflammation,” Annals of the Rheumatic Diseases, vol. 59, no. 4, pp. 303–307, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. A. W. Thomson and E. F. Fowler, “Carrageenan: a review of its effects on the immune system,” Agents and Actions, vol. 11, no. 3, pp. 265–273, 1981. View at Google Scholar · View at Scopus
  44. R. Mankes and R. Abraham, “Lysosomal dysfunction in colonic submucosal macrophages of rhesus monkeys caused by degraded iota carrageenan,” Proceedings of the Society for Experimental Biology and Medicine, vol. 150, no. 1, pp. 166–170, 1975. View at Google Scholar · View at Scopus
  45. H. Zhou, I. Wertz, K. O'Rourke et al., “Bcl10 activates the NF-κB pathway through ubiquitination of NEMO,” Nature, vol. 427, no. 6970, pp. 167–171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Dong, Y. Liu, J. Peng et al., “The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-κB from toll-like receptor 4,” The Journal of Biological Chemistry, vol. 281, no. 36, pp. 26029–26040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Takaesu, R. M. Surabhi, K. J. Park, J. Ninomiya-Tsuji, K. Matsumoto, and R. B. Gaynor, “TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway,” Journal of Molecular Biology, vol. 326, no. 1, pp. 105–115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Gaide, F. Martinon, O. Micheau, D. Bonnet, M. Thome, and J. Tschopp, “Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation,” FEBS Letters, vol. 496, no. 2-3, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Borthakur, S. Bhattacharyya, W. A. Alrefai, J. K. Tobacman, K. Ramaswamy, and P. K. Dudeja, “Platelet-activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent,” Inflammatory Bowel Diseases, vol. 16, no. 4, pp. 593–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. Encyclopædia Britannica, “algae,” Encyclopædia Britannica, Encyclopædia Britannica Online, 2010, http://search.eb.com/eb.article-31714.